Nanobiosym® was founded to create breakthrough scientific insights and transformational technologies that emerge from the convergence of physics, nanotechnology, and biomedicine.

Nanobiosym® Diagnostics (NBSDx) focuses on the commercialization of our Gene-RADAR® technology platform to empower people worldwide with rapid, accurate, and portable diagnostic information about their own health.

Through the Nanobiosym Global Initiative, we are building innovative partnerships with academic and global thought leaders, NGO’s, industries, and governments who can help us bring emerging technologies to address some of the world’s most pressing challenges.